• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM (VIPERWIRE ADVANCE); PERIPHERAL ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM (VIPERWIRE ADVANCE); PERIPHERAL ATHERECTOMY DEVICE Back to Search Results
Model Number VPR-GW-FLEX14
Device Problem Material Separation (1562)
Patient Problem Foreign Body In Patient (2687)
Event Date 04/07/2022
Event Type  Injury  
Manufacturer Narrative
The viperwire advance guide wire and diamondback 360 exchangeable orbital atherectomy device (oad) were received at csi for analysis.Visual examination confirmed that the guide wire had fractured.No other damage was observed with the guide wire or oad.Scanning electron microscopic analysis of the guide wire revealed evidence of fatigue.Review of the oad data log did not identify any issued that would have contributed to the guide wire fracture.The root cause of the guide wire fracture remains undetermined.The material inspection report for this guide wire lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.Csi id: (b)(4).
 
Event Description
Using a diamondback 360 peripheral orbital atherectomy device (oad), the physician performed 11 to 12 atherectomy treatments on all speeds in the superficial femoral artery.The treatment segment was 200cm in length including 50cm chronic total occlusion and other areas of varying degrees of stenosis.There was moderate calcium throughout with a segment of mixed morphology disease.During removal of the oad, glideassist was activated.The viperwire advance guide wire fractured near the middle of the wire.At least half of the length of the wire (approximately 200cm), remained in vivo.A snare, a non-csi catheter, and an angioplasty balloon were used to remove the remaining viperwire from the patient.The patient was discharged in good condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM (VIPERWIRE ADVANCE)
Type of Device
PERIPHERAL ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS, INC.
1225 old hwy 8 nw
st. paul MN 55112
Manufacturer Contact
kim mcclure
1225 old hwy 8 nw
st. paul, MN 55112
6519006741
MDR Report Key14288239
MDR Text Key290790813
Report Number3004742232-2022-00112
Device Sequence Number1
Product Code MCW
UDI-Device Identifier10852528005718
UDI-Public(01)10852528005718(17)230630(10)383372-1
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190634
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2023
Device Model NumberVPR-GW-FLEX14
Device Catalogue Number7-10041-03
Device Lot Number383372-1
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/24/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/07/2022
Initial Date FDA Received05/05/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexFemale
Patient Weight97 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-